Eckert & Ziegler Strahlen- und Medizintechnik AG (DE:EUZ)
XETRA:EUZ
Total Valuation
Eckert & Ziegler Strahlen und Medizintechnik has a market cap or net worth of €912.95M. The enterprise value is €821.93M.
Market Cap€912.95M
Enterprise Value€821.93M
Share Statistics
Eckert & Ziegler Strahlen und Medizintechnik has 63,515,797 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,515,797
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eckert & Ziegler Strahlen und Medizintechnik’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 11.99%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)11.99%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee287.52K
Profits Per Employee44.94K
Employee Count1,085
Asset Turnover0.64
Inventory Turnover3.58
Valuation Ratios
The current PE Ratio of Eckert & Ziegler Strahlen und Medizintechnik is 19.6. Eckert & Ziegler Strahlen und Medizintechnik’s PEG ratio is 0.42.
PE Ratio19.6
PS Ratio3.06
PB Ratio3.79
Price to Fair Value3.79
Price to FCF27.76
Price to Operating Cash Flow15.08
PEG Ratio0.42
Income Statement
In the last 12 months, Eckert & Ziegler Strahlen und Medizintechnik had revenue of 311.96M and earned 48.76M in profits. Earnings per share was 0.78.
Revenue311.96M
Gross Profit147.21M
Operating Income75.06M
Pretax Income72.77M
Net Income48.76M
EBITDA75.06M
Earnings Per Share (EPS)0.78
Cash Flow
In the last 12 months, operating cash flow was 60.41M and capital expenditures -26.02M, giving a free cash flow of 34.39M billion.
Operating Cash Flow60.41M
Free Cash Flow34.39M
Free Cash Flow per Share0.54
Dividends & Yields
Eckert & Ziegler Strahlen und Medizintechnik pays an annual dividend of €0.167, resulting in a dividend yield of 1.11%
Dividend Per Share€0.167
Dividend Yield1.11%
Payout Ratio26.25%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.27
52-Week Price Change-20.59%
50-Day Moving Average15.00
200-Day Moving Average17.21
Relative Strength Index (RSI)48.65
Average Volume (3m)108.96K
Important Dates
Eckert & Ziegler Strahlen und Medizintechnik upcoming earnings date is May 12, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Eckert & Ziegler Strahlen und Medizintechnik as a current ratio of 3.45, with Debt / Equity ratio of 14.96%
Current Ratio3.45
Quick Ratio2.81
Debt to Market Cap0.01
Net Debt to EBITDA-1.21
Interest Coverage Ratio38.67
Taxes
In the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik has paid 23.54M in taxes.
Income Tax23.54M
Effective Tax Rate0.32
Enterprise Valuation
Eckert & Ziegler Strahlen und Medizintechnik EV to EBITDA ratio is 11.51, with an EV/FCF ratio of 25.12.
EV to Sales2.77
EV to EBITDA11.51
EV to Free Cash Flow25.12
EV to Operating Cash Flow14.30
Balance Sheet
Eckert & Ziegler Strahlen und Medizintechnik has €128.76M in cash and marketable securities with €37.67M in debt, giving a net cash position of €91.09M billion.
Cash & Marketable Securities€128.76M
Total Debt€37.67M
Net Cash€91.09M
Net Cash Per Share€1.43
Tangible Book Value Per Share€3.87
Margins
Gross margin is 47.18%, with operating margin of 24.06%, and net profit margin of 15.63%.
Gross Margin47.18%
Operating Margin24.06%
Pretax Margin23.33%
Net Profit Margin15.63%
EBITDA Margin24.06%
EBIT Margin24.06%
Analyst Forecast
The average price target for Eckert & Ziegler Strahlen und Medizintechnik is €22.15, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€22.15
Price Target Upside51.82% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast9.64%
EPS Growth Forecast35.18%